Jodi M. Lestner

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring

Jodi M. Lestner, Steven A. Roberts, Caroline B. Moore et al. · Clinical Infectious Diseases · 2009 · 128 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy

Susan J. Howard, Jodi M. Lestner, Lea Gregson et al. · The Journal of Infectious Diseases · 2011 · 107 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy

Matthew Zimmerman, Jodi M. Lestner, Brendan Prideaux et al. · Antimicrobial Agents and Chemotherapy · 2017 · 81 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Systemic Antifungal Prescribing in Neonates and Children: Outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study

Jodi M. Lestner, Ann Versporten, Katja Doerholt et al. · Antimicrobial Agents and Chemotherapy · 2014 · 58 citations · Full text

Pharmacy, Child Health, Pediatrics +17

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an <i>In Vitro</i> Model of Invasive Pulmonary Aspergillosis

Jodi M. Lestner, Susan J. Howard, Joanne Goodwin et al. · Antimicrobial Agents and Chemotherapy · 2010 · 54 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17